Glass sample cubes containing capsules and cells

/ Enterprise Drug Intelligence

AI that connects trials, science, regulatory, safety, patents and competitors into one Drug Intelligence Graph.

ResourcesSee Change Radar in action

/ What we do

MOLECURIX is built exclusively for pharmaceutical and biotech companies — not patients, pharmacies or generic chat.

Pick a drug, company, indication, geography and competitor set. MOLECURIX continuously watches literature, clinical trials, regulators, pharmacovigilance, patents and pipelines, and surfaces only the changes that matter.

Open the platform
Orange cell droplets

Less manual searching, monitoring and comparing for pharma teams.

70%
Translucent molecules

/ Our approach

Tablet showing MOLECURIX dashboard
Scientist recording data on a tablet
5.2×

Faster detection of material
changes around a drug

Cell culture in glass cube
01

Drug Intelligence Graph

Connects molecule, indication, trials, patents, safety signals and competitors in one evidence graph.

02

Change Radar

e.g. Semaglutide: 12 material changes detected — clinical, scientific, regulatory and safety.

Industries

Built for R&D, clinical, medical affairs, pharmacovigilance, regulatory, competitive intelligence, BD and leadership teams.

Global frameworks

Biotech visual

Biotech

Biotech industry

Monitor the science, trials and competitors around every asset in your pipeline — from preclinical to approval.

Industry sector

Pharmaceutical visual

Pharmaceutical

Discovery platforms

AI Drug Discovery visual

AI Drug Discovery

Glass knot filled with blue beads

We connect fragmented evidence around your drug and explain why each change matters.

Change Radar
Evidence Graph

Sources monitored

PubMedLiterature
CT.govTrials
FDARegulatory
EMARegulatory
FAERSSafety

/ Technology

Evidence Connection

Links papers, trials, filings and patents to the drug, indication and competitor they affect.

MOLECURIX platform

All-in-one
Platform

Change Radar · Semaglutide
Jul 18, 2026
Jul 17, 2026
Jul 16, 2026
Jul 20, 2026

One workspace for change detection, evidence and AI explanations across your whole portfolio.

Safety & Regulatory Watch

Automated tracking of regulatory communications and pharmacovigilance signals across authorities.

Solutions

Intelligence modules across every source that shapes a drug’s trajectory.

/ Case studies

BiotechnologyCase Study

Spotting a competitor Phase III early

Change Radar flagged a new competitor Phase III registration in the same indication days after posting.

Spotting a competitor Phase III early
PharmaceuticalCase Study

Connecting a safety signal to the label

A new pharmacovigilance cluster was linked to prior literature and an agency communication in one view.

Connecting a safety signal to the label
AI Drug DiscoveryCase Study

Tracking patents around a new target

New patent filings on the same mechanism were surfaced and mapped to the discovery team’s candidates.

Tracking patents around a new target

Book a demo of Change Radar and the Drug Intelligence Graph for your portfolio.

Book a demoGlass rings filled with blue beads